The Norwegian Institute of Public Health (NIPH) will conduct an open tender contest for the purchase of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (DTP-Polio-Hib) for primary immunisation for use in the "Norwegian Childhood Immunisation Programme". The contest will be carried out as an open tender contest, a one-step process, where all interested service providers can submit tenders. Negotiations will not be allowed. The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (for primary immunisation: DPT-Hib-Polio) (ATC code: J07CA06) with an estimated number of between 180 000 and 240 000 doses per year for use in the Norwegian Childhood Immunisation programme. The vaccine shall be offered to infants, in 3 doses, at the ages of 3, 5 and 11-12 months. The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from about 720 000 to about 960 000 doses. Note: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at http://www.doffin.no/Search/Search_Switch.aspx?ID=274125.
Frist
Fristen for mottak av tilbud var 2013-01-21.
Anskaffelsen ble publisert 2012-11-27.
Kunngjøring av konkurranse (2012-11-27) Gjenstand Anskaffelsens omfang
Tittel: diphtheria-pertussis-tetanus vaccines
Antall eller omfang:
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis, Haemophilus influensae type b and poliomyelitis (DTP-Hib-polio) (ATC code:J07CA06) with an approximate number of between 180 000 and 240 000 doses per year for use in the "Norwegian Childhood Immunisation programme".The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from approx. 720 000 to approx. 960 000 doses.
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis, Haemophilus influensae type b and poliomyelitis (DTP-Hib-polio) (ATC code:J07CA06) with an approximate number of between 180 000 and 240 000 doses per year for use in the "Norwegian Childhood Immunisation programme".The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from approx. 720 000 to approx. 960 000 doses.
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner mot difteri, kikhoste og stivkrampe📦
Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet
Oppdragsgiver Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Nasjonalt folkehelseinstitutt
Postadresse: Lovisenberggata 8,
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no/🌏
E-post: ole.andreas.fuglesang@fhi.no📧
Telefon: +47 21076629📞
The tender documents have only been drawn up in Norwegian and the awarding authority will not be providing translations into other languages.
(NT Ref:274150).
Gjenstand Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) will conduct an open tender contest for the purchase of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (DTP-Polio-Hib) for primary immunisation for use in the "Norwegian Childhood Immunisation Programme". The contest will be carried out as an open tender contest, a one-step process, where all interested service providers can submit tenders. Negotiations will not be allowed.
The Norwegian Institute of Public Health (NIPH) will conduct an open tender contest for the purchase of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (DTP-Polio-Hib) for primary immunisation for use in the "Norwegian Childhood Immunisation Programme". The contest will be carried out as an open tender contest, a one-step process, where all interested service providers can submit tenders. Negotiations will not be allowed.
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (for primary immunisation: DPT-Hib-Polio) (ATC code: J07CA06) with an estimated number of between 180 000 and 240 000 doses per year for use in the Norwegian Childhood Immunisation programme.
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis (acellular), Haemophilus influenzae type b and poliomyelitis (for primary immunisation: DPT-Hib-Polio) (ATC code: J07CA06) with an estimated number of between 180 000 and 240 000 doses per year for use in the Norwegian Childhood Immunisation programme.
The vaccine shall be offered to infants, in 3 doses, at the ages of 3, 5 and 11-12 months.
The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from about 720 000 to about 960 000 doses.
The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from about 720 000 to about 960 000 doses.
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis, Haemophilus influensae type b and poliomyelitis (DTP-Hib-polio) (ATC code:J07CA06) with an approximate number of between 180 000 and 240 000 doses per year for use in the "Norwegian Childhood Immunisation programme".
The assignment comprises the delivery of a combined vaccine against diphtheria, tetanus, pertussis, Haemophilus influensae type b and poliomyelitis (DTP-Hib-polio) (ATC code:J07CA06) with an approximate number of between 180 000 and 240 000 doses per year for use in the "Norwegian Childhood Immunisation programme".
The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from approx. 720 000 to approx. 960 000 doses.
The contract is for 2013 and 2014 and is automatically extended by one year at a time for up to two years, unless award authority cancels the contract by 1.7.2014 or 1.7.2015 respectively. Total number of doses for the contract period, including the full option will therefore be from approx. 720 000 to approx. 960 000 doses.